Research Grade Anti-Human CD272/BTLA Antibody (22B3)Anti-Human CD272/BTLA Antibody (22B3) ( HV375046 ) is a research-grade recombinant antibody targeting CD272 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | B- and T-lymphocyte attenuator, BTLA, CD272, B- and T-lymphocyte-associated protein | | Accession | Q7Z6A9 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-523-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-Human CD272/BTLA Antibody (22B3).
Примечание: |
|
